[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2000044467A - Agent for stimulating blood flow - Google Patents

Agent for stimulating blood flow

Info

Publication number
JP2000044467A
JP2000044467A JP10230287A JP23028798A JP2000044467A JP 2000044467 A JP2000044467 A JP 2000044467A JP 10230287 A JP10230287 A JP 10230287A JP 23028798 A JP23028798 A JP 23028798A JP 2000044467 A JP2000044467 A JP 2000044467A
Authority
JP
Japan
Prior art keywords
blood flow
agent
citral
active ingredient
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10230287A
Other languages
Japanese (ja)
Inventor
Fumihiko Tokida
文彦 常田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP10230287A priority Critical patent/JP2000044467A/en
Publication of JP2000044467A publication Critical patent/JP2000044467A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject agent having an excellent blood flow-stimulating effect, hardly having the problems of smell, irritation, etc., on employment, giving a high refreshing feeling, having a good touch, and useful as an ingredient for compositions for oral cavities, medicines, cosmetics, etc., by adding citral as an active ingredient. SOLUTION: This agent for stimulating the flow of blood contains as an active ingredient citral which is obtained from a plant such as lemon grass as a fractionated product or an isolated product or obtained as a synthesized product. The agent can be added to hair tonics, bathing agents, preparations for external uses, etc., preferably in an amount of 0.1-5% based on the total amount of the preparation to which the citral is added. The agent is useful for periodontal diseases, the improvement of skin drabness and alopecia, etc.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、優れた血流促進効
果を有し、口腔用組成物、医薬品、化粧品等に好適に配
合、使用することができる血流促進剤に関する。
TECHNICAL FIELD The present invention relates to a blood flow promoting agent which has an excellent blood flow promoting effect and can be suitably blended and used in oral compositions, pharmaceuticals, cosmetics and the like.

【0002】[0002]

【従来の技術】一般に血流量は血管内径の4乗に比例す
るといわれており、動脈、特に細動脈の内径の狭少化
は、支配領域の長期にわたる動脈血供給不全を招く。こ
の動脈血供給不全は、局所組織の代謝障害(萎縮、変
性、壊死)を起こし、口腔内においては歯周疾患、皮膚
では「くすみ」、頭髪では脱毛、その他肩こり、筋肉痛
などの障害として現れる。
2. Description of the Related Art It is generally said that the blood flow is proportional to the fourth power of the inner diameter of a blood vessel, and narrowing of the inner diameter of an artery, particularly an arteriole, leads to a long-term inadequate supply of arterial blood in the governing region. This inadequate arterial blood supply causes metabolic disorders (atrophy, degeneration, necrosis) in local tissues, and appears as disorders such as periodontal disease in the oral cavity, "dullness" in the skin, hair loss in the hair, stiff shoulders, and muscle pain.

【0003】そこで、これらの血流促進障害を改善する
ものとして、様々な製剤が開発されている。具体的に
は、血流を改善するものとしてビタミンE(トコフェロ
ール)やカロペプタイドを配合した歯磨(特公昭45−
23636号公報)、歯周疾患の予防・治療用としてヒ
ノキ、西洋トチノキ、アルニカ等の植物の溶媒抽出物と
カロペプタイドとを併用した口腔用組成物(特開昭57
−82307号公報)が提案されている。また、植物精
油成分の血流促進剤としてケイヒアルデヒド等のシンナ
モイル型化合物(特開平7−258074号公報)、ア
セチルオイゲノール等のオイゲノール誘導体(特開平9
−241116号公報)も提案されている。
[0003] Therefore, various preparations have been developed to improve these blood flow promoting disorders. Specifically, dentifrices containing vitamin E (tocopherol) and caropeptides to improve blood flow (Japanese Patent Publication No.
No. 23636), a composition for oral cavity using a solvent extract of a plant such as hinoki, western horse chestnut, arnica and the like in combination with a caropeptide for the prevention and treatment of periodontal disease (Japanese Patent Application Laid-Open No. Sho 57)
-82307) has been proposed. In addition, cinnamoyl-type compounds such as cinnamaldehyde (JP-A-7-258074), and eugenol derivatives such as acetyleugenol (JP-A-9-209) are used as blood flow enhancers for plant essential oil components.
-241116) has also been proposed.

【0004】[0004]

【発明が解決しようとする課題】しかしながら、トコフ
ェロールやカロペプタイドは、血流促進効果が十分満足
できるものとは言い難く、また、シンナモイル型化合物
やオイゲノール誘導体は、効果は優れているが清涼感の
ある香りではない。更に、カプサイシンも血流促進効果
を有することが知られているが、清涼感が得られないと
いう欠点があった。従って、清涼感が強く、より高い血
流促進効果を発揮し得る高品質の血流促進剤の開発が望
まれる。
However, it is hard to say that tocopherol and caropeptide have a satisfactory blood flow promoting effect, and cinnamoyl-type compounds and eugenol derivatives have a good effect but a refreshing feeling. Not a scent. Furthermore, although capsaicin is also known to have a blood flow promoting effect, it has a drawback that a refreshing feeling cannot be obtained. Therefore, it is desired to develop a high-quality blood flow promoting agent that has a strong cooling sensation and can exhibit a higher blood flow promoting effect.

【0005】本発明は、上記事情に鑑みなされたもの
で、優れた血流促進効果を有し、清涼感が高く、使用感
の良好な血流促進剤を提供することを目的とする。
The present invention has been made in view of the above circumstances, and it is an object of the present invention to provide a blood flow promoting agent having an excellent blood flow promoting effect, a high refreshing feeling, and a good feeling in use.

【0006】[0006]

【課題を解決するための手段及び発明の実施の形態】本
発明者は、上記目的を達成するため鋭意検討を重ねた結
果、香料等として公知のシトラールが、意外にも末梢血
流低下による局所組織の代謝障害を改善して高い血行促
進効果を発揮すること、それ故、シトラールを血行促進
の有効成分とすることにより、優れた血流促進効果を有
し、しかも香りや刺激などの使用上の問題が少なく、清
涼感も高く、使用感も良好で、口腔用組成物、医薬品、
化粧品等に配合、使用できる血流促進剤が得られること
を知見し、本発明をなすに至った。
Means for Solving the Problems and Embodiments of the Invention The present inventors have conducted intensive studies in order to achieve the above object, and as a result, citral, which is known as a fragrance, has been surprisingly localized due to a decrease in peripheral blood flow. Improves tissue metabolic disorders and exerts a high blood circulation promoting effect. Therefore, by using citral as an active ingredient for promoting blood circulation, it has an excellent blood flow promoting effect and is suitable for use such as fragrance and irritation. There are few problems, refreshing feeling is high, feeling of use is good, oral compositions, pharmaceuticals,
The present inventors have found that a blood flow promoter which can be blended and used in cosmetics and the like can be obtained, and have accomplished the present invention.

【0007】なお、シトラールは、上記したように香料
成分として利用されているほか、タバコのヤニを除去す
る効果に優れ、これを含む口腔用組成物が提案されてい
る(特開昭62−181212号公報)。しかし、シト
ラールが上記のような優れた血流促進効果を有すること
は未だ知られておらず、このことは本発明者により初め
て見出されたものである。
Citral is used not only as a flavor component as described above, but also has an excellent effect of removing tarnish from tobacco, and an oral composition containing the same has been proposed (Japanese Patent Application Laid-Open No. Sho 62-181212). No.). However, it has not yet been known that citral has such an excellent blood flow promoting effect as described above, and this was first discovered by the present inventors.

【0008】従って、本発明は、シトラールを有効成分
とする血流促進剤を提供する。
Accordingly, the present invention provides a blood flow enhancer containing citral as an active ingredient.

【0009】以下、本発明につき更に詳細に説明する
と、本発明の血流促進剤の有効成分であるシトラール
は、これらを含む植物からの分画物や単離品として、或
いは合成品として得ることができる。この場合シトラー
ルを植物からの分画物や単離品として得る場合は、例え
ばシトラールを含む植物を公知の方法で分画して抽出物
や精油を得たり、更に公知の方法で分画して単離品を得
ることができる。シトラールを含む植物としては、具体
的に下記植物などを挙げることができる。イネ科オガル
カヤ属、特にレモングラスと称されるCymbopog
on citratus(D.C.)Stapf.(シ
ンボポゴン・シトラトゥス)、C.flexuosus
(D.C.)Stapf.(フレクスオスス)、C.p
endulus Stapf.(ペンドゥルス)など。
クマツヅラ科イワダレソウ属、特にレモンベルベナ(L
ippia citriodora H.B.et K
iut.)など。シソ科シソ属、特にレモンエゴマ(P
erilla frutescens Brit.)な
ど。ミカン科ミカン属、特にCitrus auran
tifolia Swing.(シトルス・アウランテ
ィフォリア)、C.aurantium L.(アウラ
ンティウム)、C.histrix D.C.(ヒスト
リクス)、C.lemon(L.)Burm.f.(レ
モン)、C.limetta Russo(リメッ
タ)、C.maxima(Burn.f.)Merr.
(マクシマ)、C.medica L.(メディカ)、
C.paradisi Mac fayden(パラデ
ィシ)、C.reticulata Blanco(レ
ティクラタ)、C.sinensis Osbeck
(シネンシス)など。及びこれらの亜種、変種など。
The present invention will be described in more detail below. Citral, which is an active ingredient of the blood flow enhancer of the present invention, can be obtained as a fraction or an isolated product from a plant containing the same or as a synthetic product. Can be. In this case, when citral is obtained as a fraction or an isolated product from a plant, for example, a plant containing citral is fractionated by a known method to obtain an extract or an essential oil, or further fractionated by a known method. An isolate can be obtained. Specific examples of plants containing citral include the following plants. Cymbopog of the genus Ogarukaya, especially lemongrass
on citratus (DC) Stap. (Symbopogon Citratus), C.I. flexuosus
(DC) Stapf. (Flex male), C.I. p
endulus Stapf. (Pendulus) and so on.
Lilium spp., Especially Lemon Verbena (L
ipia citriodora H .; B. et K
it. )Such. Lamiaceae Lamiaceae, especially lemon perilla (P
erilla flutescens Brit. )Such. Citrus citrus, especially Citrus auran
tifolia Swing. (Citrus aurantifolia), C.I. aurantium L. (Aurantium), C.I. histrix D. C. (History), C.I. lemon (L.) Burm. f. (Lemon), C.I. limetta Russo (Limetta), C.I. maxima (Burn.f.) Merr.
(Maxima), C.I. medica L. (Medica),
C. paradisi Macfayden (Paradisi), C.I. C. reticulata Blanco (Reticulata), C.I. sinensis Osbeck
(Sinensis). And their subspecies, variants, etc.

【0010】本発明では、有効成分としてシトラール又
はそれを含有する植物抽出物と共にその他の既存の血流
促進成分を併用して配合することができ、このように他
の血流促進成分を併用することにより、清涼感をもっ
た、より強い血流促進効果を発揮することができる。
In the present invention, citral or a plant extract containing the same can be used as an active ingredient in combination with other existing blood flow-promoting components, and thus other blood flow-promoting components can be used in combination. Thereby, a stronger blood flow promoting effect having a refreshing feeling can be exerted.

【0011】ここで、他の血流促進成分としては、例え
ばケイヒアルデヒド、オイゲノール、カルバクロール、
チモール、カプサイシン、ジンゲロール、センブリエキ
ス、ニンジンエキス、ニンニクエキス、トコフェロール
等を挙げることができる。
Here, the other blood flow promoting components include, for example, cinnamaldehyde, eugenol, carvacrol,
Examples include thymol, capsaicin, gingerol, assembly extract, carrot extract, garlic extract, and tocopherol.

【0012】本発明の血流促進剤は、例えば口腔用組成
物、化粧品、医薬品、育毛剤、浴用剤、外用剤などに配
合して使用することができる。
The blood flow enhancer of the present invention can be used, for example, by blending it in oral compositions, cosmetics, pharmaceuticals, hair restorers, bath agents, external preparations and the like.

【0013】この場合、本発明のシトラールを含有する
血流促進剤の配合量は、そのシトラール成分量が配合す
る製剤全体の0.01〜10%(重量%、以下同様)、
特に0.1〜5%となる範囲が好ましく、配合量が0.
01%に満たないと満足な血流促進効果が発揮されない
場合があり、10%を超えると配合する製剤の安定性や
香味を損なう場合がある。
In this case, the amount of the citral-containing blood flow promoting agent of the present invention is 0.01 to 10% (% by weight, hereinafter the same) of the whole preparation to which the citral component is added.
In particular, the range of 0.1 to 5% is preferable, and the blending amount is 0.1%.
If it is less than 01%, a satisfactory blood flow promoting effect may not be exhibited, and if it exceeds 10%, the stability and flavor of the formulation may be impaired.

【0014】本発明の血流促進剤を口腔用組成物、医薬
品、化粧品、育毛剤、浴用剤、外用剤等に配合する場
合、これら製剤には、通常その製剤に使用されている成
分を用いることができ、これら成分の添加量は、本発明
の効果を妨げない範囲で通常量とすることができる。
When the blood flow enhancer of the present invention is blended with an oral composition, a pharmaceutical, a cosmetic, a hair restorer, a bath preparation, an external preparation, etc., the components usually used in the preparation are used. These components can be added in usual amounts as long as the effects of the present invention are not impaired.

【0015】[0015]

【発明の効果】本発明の血流促進剤は、末梢血流低下に
よる局所組織の代謝障害を改善して優れた血流促進効果
を発揮し、しかも香りや刺激などの使用上の問題が少な
く、高い清涼感を有し、使用感にも優れたもので、口腔
用組成物、医薬品、化粧品、育毛剤、浴用剤、外用剤等
に配合して、歯周疾患、皮膚のくすみ、脱毛、肩こり、
筋肉痛等の改善などに使用できる。
Industrial Applicability The blood flow enhancer of the present invention improves metabolic disorders in local tissues due to a decrease in peripheral blood flow, exhibits an excellent blood flow promoting effect, and has few problems in use such as fragrance and irritation. It has a high refreshing sensation and excellent feeling in use.It is blended in oral compositions, pharmaceuticals, cosmetics, hair restorers, bath preparations, external preparations, etc. to provide periodontal disease, dull skin, hair loss, Stiff shoulder,
It can be used to improve muscle pain.

【0016】[0016]

【実施例】以下、実施例及び比較例、配合例を挙げて本
発明を具体的に説明するが、本発明は下記実施例に限定
されるものではない。なお、下記の例において%はいず
れも重量%である。
EXAMPLES Hereinafter, the present invention will be described specifically with reference to Examples, Comparative Examples, and Formulation Examples, but the present invention is not limited to the following Examples. In addition, in the following examples, all% are weight%.

【0017】[実施例、比較例]血流促進評価 レーザー・ドプラー血流測定装置(PERIFLUX
PF1b、スウェーデン・ペリメッド社製)を用い、表
1に示すサンプルをエタノールに5%溶解し、前腕内側
の皮膚に貼り付けたプローブホルダー中に10μl滴下
後、血流量変化を経時的に観察した。計測値はAD変換
し、コンピュータに取り込み、1分間毎の平均値をプロ
ットした。このグラフから血流量の最高値を基底値で割
った値を血流促進倍率として表1に示した。
[0017] Examples and Comparative Examples bloodstream promoting evaluation laser Doppler blood flow measuring device (Periflux
Using PF1b (manufactured by Perimed, Sweden), the samples shown in Table 1 were dissolved at 5% in ethanol, and 10 μl of the sample was dropped into a probe holder attached to the skin inside the forearm. The measured value was AD-converted, taken into a computer, and the average value per minute was plotted. Table 1 shows the value obtained by dividing the highest value of the blood flow rate by the base value from this graph as the blood flow promotion magnification.

【0018】清涼感の強さの評価 血流測定用溶液(サンプル5%のエタノール溶液)を濾
紙に浸し、次の基準で官能評価した。結果を表1に示
す。 +++ 清涼感が非常に強い ++ 清涼感が強い + かすかに清涼感がある − 清涼感なし
Evaluation of Refreshing Sensitivity A solution for measuring blood flow (a 5% ethanol solution of a sample) was immersed in filter paper and subjected to sensory evaluation according to the following criteria. Table 1 shows the results. ++ Very refreshing ++ Very refreshing + Slightly refreshing-No refreshing

【0019】[0019]

【表1】 [Table 1]

【0020】以下、処方例を示す。 [配合例1]練歯磨 沈降性シリカ 25.00 % グリセリン 25.00 ソルビット 15.00 キシリトール 10.00 ラウロイルデカグリセリンエステル 1.00 ミリスチン酸ジエタノールアミド 2.00 香 料 1.00 サッカリンナトリウム 0.20 レモングラスオイル 1.00水 残 計 100.00 % In the following, prescription examples are shown. [Formulation Example 1] Toothpaste Precipitated silica 25.00% Glycerin 25.00 Sorbit 15.00 Xylitol 10.00 Lauroyldecaglycerin ester 1.00 Myristic acid diethanolamide 2.00 Fragrance 1.00 Saccharin sodium 0.20 Lemon Glass oil 1.00 water balance 100.00%

【0021】 [配合例2]液状歯磨 沈降性シリカ 20.00 % グリセリン 25.00 ソルビット 35.00 キサンタンガム(薬添規適合品) 0.20 プロピレングリコール 2.00 ラウリル硫酸ナトリウム 1.50 モノラウリン酸デカグリセリル 2.00 香 料 0.50 サッカリンナトリウム 0.10 チモール 0.50 シトラール 0.50水 残 計 100.00 %[Formulation Example 2] Liquid dentifrice Precipitable silica 20.00% Glycerin 25.00 Sorbit 35.00 Xanthan gum (compliant with pharmaceutical standards) 0.20 Propylene glycol 2.00 Sodium lauryl sulfate 1.50 Decaglyceryl monolaurate 2.00 Fragrance 0.50 Saccharin sodium 0.10 Thymol 0.50 Citral 0.50 Water Balance 100.00%

【0022】 [配合例3]口腔用軟膏 流動パラフィン 15.00 % セタノール 10.00 グリセリン 20.00 ポリオキシエチレンソルビタン脂肪酸エステル 5.00 香 料 0.50 サッカリンナトリウム 0.10 ベルベナオイル 1.50水 残 計 100.00 %[Formulation Example 3] Oral ointment Liquid paraffin 15.00% Cetanol 10.00 Glycerin 20.00 Polyoxyethylene sorbitan fatty acid ester 5.00 Fragrance 0.50 Saccharin sodium 0.10 Verbena oil 1.50 Water Balance 100.00%

【0023】 [配合例4]洗口液 エタノール 20.00 % 香 料 1.00 ポリオキシエチレン硬化ヒマシ油(EO=60) 0.30 モノフルオロリン酸ナトリウム 0.10 サッカリンナトリウム 0.05 レモンエゴマオイル 1.50水 残 計 100.00 %[Formulation Example 4] Mouthwash Ethanol 20.00% Fragrance 1.00 Polyoxyethylene hydrogenated castor oil (EO = 60) 0.30 Sodium monofluorophosphate 0.10 Saccharin sodium 0.05 Lemon perilla oil 1.50 water balance 100.00%

【0024】 [配合例5]キャンディ 砂 糖 50.00 % 水 飴 33.00 有 機 酸 2.00 香 料 0.20 カルバクロール 0.50 レモングラスのn−ヘキサン抽出物 0.50水 残 計 100.00 %[Formulation Example 5] Candy sugar 50.00% water candy 33.00 Organic acid 2.00 Flavor 0.20 Carvacrol 0.50 Lemongrass n-hexane extract 0.50 Water balance 100.00%

【0025】 [配合例6]チューインガム 砂 糖 53.00 % ガムベース 20.00 グルコース 10.00 水 飴 16.00 香 料 0.50レモンオイル 1.50 計 101.00 %[Formulation Example 6] Chewing gum sugar 53.00% Gum base 20.00 Glucose 10.00 Water candy 16.00 Flavor 0.50 Lemon oil 1.50 Total 101.00%

【0026】 [配合例7]化粧用クリーム ステアリン酸 2.00 % ステアリルアルコール 7.00 ポリオキシエチレンセチルエーテル(EO=25) 4.00 プロピレングリコール 8.00 水添ラノリン 2.00 2−オクチルドデシルアルコール 6.00 グリセリンモノステアリン酸エステル 2.00 スクワラン 5.00 香 料 0.50 シトロンリーフオイル 1.00水 残 計 100.00 %[Formulation Example 7] Cosmetic cream stearic acid 2.00% stearyl alcohol 7.00 polyoxyethylene cetyl ether (EO = 25) 4.00 propylene glycol 8.00 hydrogenated lanolin 2.00 2-octyldodecyl Alcohol 6.00 Glycerin monostearate 2.00 Squalane 5.00 Fragrance 0.50 Citron leaf oil 1.00 Water Balance 100.00%

【0027】 [配合例8]育毛剤 エタノール 60.00 % グリセリン 0.50 香 料 0.50 ポリオキシエチレン硬化ヒマシ油(EO=60) 0.50 酢酸トコフェロール 0.10 シトラール 0.50 レモンオイル 1.00 水 残 計 100.00 %[Formulation Example 8] Hair restorer ethanol 60.00% glycerin 0.50 flavoring agent 0.50 polyoxyethylene hydrogenated castor oil (EO = 60) 0.50 tocopherol acetate 0.10 citral 0.50 lemon oil 1 0.00 water balance 100.00%

【0028】 [配合例9]浴用剤 硫酸ナトリウム 46.00 % 炭酸水素ナトリウム 13.00 炭酸ナトリウム 13.00 リンゴ酸 26.00 ポリエチレングリコール400 1.00 香 料 0.50レモングラスオイル 0.50 計 100.00 %[Formulation Example 9] Bath agent Sodium sulfate 46.00% Sodium hydrogen carbonate 13.00 Sodium carbonate 13.00 Malic acid 26.00 Polyethylene glycol 400 1.00 Fragrance 0.50 Lemongrass oil 0.50 Total 100.00%

【0029】 [配合例10]消炎鎮痛リニメント剤 エタノール 45.00 % インドメタシン 1.00 ポリオキシエチレンラウリルエーテル(EO=21) 1.00 アジピン酸イソプロピル 5.00 1,3−ブタンジオール 10.00 ベルベナオイル 1.00水 残 計 100.00 %[Formulation Example 10] Antiphlogistic analgesic liniment agent Ethanol 45.00% Indomethacin 1.00 Polyoxyethylene lauryl ether (EO = 21) 1.00 Isopropyl adipate 5.00 1,3-Butanediol 10.00 Verbena oil 1.00 water balance 100.00%

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/50 A61K 7/50 // A23L 1/30 A23L 1/30 B Fターム(参考) 4B018 LB01 LE05 MS03 4C083 AA122 AB172 AB312 AB352 AB472 AC022 AC072 AC092 AC102 AC122 AC132 AC182 AC211 AC212 AC242 AC302 AC352 AC402 AC422 AC432 AC472 AC542 AC782 AC852 AC862 AD042 AD352 AD512 AD662 CC03 CC05 CC25 CC37 CC41 DD22 DD23 DD27 DD31 EE11 EE22 EE31 EE41 4C206 AA01 AA02 CB02 KA18 MA01 MA04 NA14 ZA36 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/50 A61K 7/50 // A23L 1/30 A23L 1/30 BF Term (Reference) 4B018 LB01 LE05 MS03 4C083 AA122 AB172 AB312 AB352 AB472 AC022 AC072 AC092 AC102 AC122 AC132 AC182 AC211 AC212 AC242 AC302 AC352 AC402 AC422 AC432 AC472 AC542 AC782 AC852 AC862 AD042 AD352 AD512 AD662 CC03 CC05 CC25 CC37 CC41 DD22 DD23 DD27 DD31 EE11 AE18 EE11 AE22 MA04 NA14 ZA36

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 シトラールを有効成分として含有してな
ることを特徴とする血流促進剤。
1. A blood flow promoter comprising citral as an active ingredient.
JP10230287A 1998-07-31 1998-07-31 Agent for stimulating blood flow Pending JP2000044467A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10230287A JP2000044467A (en) 1998-07-31 1998-07-31 Agent for stimulating blood flow

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10230287A JP2000044467A (en) 1998-07-31 1998-07-31 Agent for stimulating blood flow

Publications (1)

Publication Number Publication Date
JP2000044467A true JP2000044467A (en) 2000-02-15

Family

ID=16905457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10230287A Pending JP2000044467A (en) 1998-07-31 1998-07-31 Agent for stimulating blood flow

Country Status (1)

Country Link
JP (1) JP2000044467A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126366A (en) * 2003-10-23 2005-05-19 Nippon Menaade Keshohin Kk TESTOSTERONE-5alpha-REDUCTASE INHIBITOR
JP2007039445A (en) * 2005-07-01 2007-02-15 Kikkoman Corp Prostacyclin production-increasing agent and blood flow-enhancing agent
JP2007051090A (en) * 2005-08-18 2007-03-01 Pharma Foods International Co Ltd Blood flow improving agent containing egg white peptide as active ingredient
WO2009063807A1 (en) * 2007-11-15 2009-05-22 Anbas Corporation Method for evaluation of hair growth-promoting activity, and method for screening of substance capable of promoting the hair growth, and hair growth promoter
WO2009063931A1 (en) * 2007-11-15 2009-05-22 Anbas Corporation Method for evaluation of blood circulation-promoting activity, method for screening of blood circulation-promoting substance, and blood circulation promoter
JP2009137951A (en) * 2007-11-15 2009-06-25 Poonsook Lohajoti Skin moisturizer, blood circulation promoter, and external preparation for skin containing the same
JP2010001227A (en) * 2008-06-18 2010-01-07 Kao Corp Hair-growing agent, nfat signal inhibitor and calcineurin inhibitor
WO2019017677A3 (en) * 2017-07-18 2019-03-07 연세대학교 산학협력단 Composition comprising citral as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126366A (en) * 2003-10-23 2005-05-19 Nippon Menaade Keshohin Kk TESTOSTERONE-5alpha-REDUCTASE INHIBITOR
JP2007039445A (en) * 2005-07-01 2007-02-15 Kikkoman Corp Prostacyclin production-increasing agent and blood flow-enhancing agent
JP2007051090A (en) * 2005-08-18 2007-03-01 Pharma Foods International Co Ltd Blood flow improving agent containing egg white peptide as active ingredient
WO2009063807A1 (en) * 2007-11-15 2009-05-22 Anbas Corporation Method for evaluation of hair growth-promoting activity, and method for screening of substance capable of promoting the hair growth, and hair growth promoter
WO2009063931A1 (en) * 2007-11-15 2009-05-22 Anbas Corporation Method for evaluation of blood circulation-promoting activity, method for screening of blood circulation-promoting substance, and blood circulation promoter
JP2009137951A (en) * 2007-11-15 2009-06-25 Poonsook Lohajoti Skin moisturizer, blood circulation promoter, and external preparation for skin containing the same
JP2009139371A (en) * 2007-11-15 2009-06-25 Anbas:Kk Evaluation method of blood circulation accelerating activity, blood circulation accelerating substance screening method and blood circulation accelerating agent
JP2010001227A (en) * 2008-06-18 2010-01-07 Kao Corp Hair-growing agent, nfat signal inhibitor and calcineurin inhibitor
WO2019017677A3 (en) * 2017-07-18 2019-03-07 연세대학교 산학협력단 Composition comprising citral as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression

Similar Documents

Publication Publication Date Title
EP3134081B1 (en) Cyclohexanecarboxamide with cooling properties
JP5665888B2 (en) Oral care composition
JP2015212274A (en) Oral care composition
JP3665360B2 (en) Active oxygen scavenger and composition containing the same
KR101383217B1 (en) Composition for preventing hair loss and promoting hair growth
JP2007204426A (en) Hair growth promoter
JP2000044467A (en) Agent for stimulating blood flow
JPH11255636A (en) Blood circulation promoter
JP2000191493A (en) Medicated cosmetic
JP2002255827A (en) Skin care preparation
JPH1036282A (en) Agent for suppressing breakage of mucopolysaccharide
KR101307304B1 (en) Composition for treating hair or scalp to prevent hair loss and promote growing hair
JP4469617B2 (en) Hair restoration
JP2696523B2 (en) Anti-dandruff agent and hair cosmetic
JP6249588B2 (en) Oral composition
JP6175280B2 (en) Composition for improving pores
KR101321045B1 (en) Composition of preventing hair loss and promoting hair growth
JP3853773B2 (en) Hair nourishing
JP2000169326A (en) Bloodstream promoter
JP2005200357A (en) Hair-fostering cosmetic
JP2003206483A (en) Antioxidant and skin care preparation
JP2001131027A (en) Hair tonic and shampoo
CN109745262A (en) A kind of composition for Whitening, spot face cream
JP3560424B2 (en) Antibacterial composition
JP2005089394A (en) Hair tonic